BARNSTABLE, Mass., March 27, 2013 /PRNewswire/ -- UV Flu
Technologies, Inc. (OTCQB: UVFT) (the "Company") announced
today that the Company has retained Stardust Broadcasting to run
approximately 500 sixty-second television spots on a variety of
national stations, with the intent of building the brand, and
educating the consumer about the dangers of indoor air
pollution.
"These commercials are the beginning of a long-term program to
drive sales, while informing viewers how they can protect their
loved ones from the spread of airborne diseases, allergens, and
virtually all other forms of indoor air pollution. According to
Stardust, the ads will start running later this week on stations
such as CNN, ESPN, Fox News, Fox Sports and the Discovery Channel,"
said Jack Lennon, President of UV
Flu.
"We are very excited about this first phase of our ramp-up. We
have spent the last 18 months testing and evaluating the many
applications for our products, and now we can focus on ramping up
production to meet the demand we foresee from addressing the needs
of each of these markets," said Mr. Lennon
"It turns out that there are major subsets to the overall
residential market that are huge, but need user specific marketing
approaches that we are now rolling out. If you have allergies or
asthma, are pregnant or have small children, are undergoing any
medical treatments, own a pet bird, dog, or cat, are a smoker or
the spouse of a smoker, if your home suffers from mold and mildew,
if you snore or have sleep problems, or are the spouse of one, or
if you work in the field of medicine, education, travel or retail,
your health, and the health of your family could be at risk," said
Mr. Lennon.
Further details regarding the Company's business, acquisitions,
financial reports and agreements are filed as part of the Company's
continuous public disclosure as a reporting issuer under the
Securities Exchange Act of 1934 filed with the Securities and
Exchange Commission's ("SEC") EDGAR database. For more
information, visit: www.uvflutech.com, and click on the 5 minute
video describing the ViraTech UV-400.
About UV Flu Technologies, Inc. (OTCQB: UVFT)
UV Flu Technologies is an innovative developer; manufacturer and
distributor of bio technology products initially targeting the
rapidly growing Indoor Air Quality ("IAQ") industry sector
($7 billion in 2011). The Company
manufactures the ViraTech UV-400, which utilizes high-intensity
ultraviolet radiation (UV-C) inside a killing chamber that goes
beyond filtration to destroy harmful airborne bacteria, at rates
exceeding 99.2% on a first-pass basis, while also reducing the
concentrations of odors, and VOC's (volatile organic compounds,
such as acetone, benzene, formaldehyde, etc.) The FDA has
issued a coveted Class II medical listing that enables UV Flu
Technologies to market the product as a medical device. For more
information, visit: www.uvflutech.com.
Notice Regarding Forward-Looking Statements
This news
release contains "forward-looking statements" as that term is
defined in Section 27A of the United States Securities Act of 1933,
as amended and Section 21E of the Securities Exchange Act of 1934,
as amended. Statements in this press release which are not purely
historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include,
among other things, the development, costs and results of new
business opportunities. Actual results could differ from those
projected in any forward-looking statements due to numerous
factors. Such factors include, among others, the inherent
uncertainties associated with new projects and development stage
companies. These forward-looking statements are made as of the date
of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans,
expectations and intentions contained in this press release are
reasonable, there can be no assurance that any such beliefs, plans,
expectations or intentions will prove to be accurate. Investors
should consult all of the information set forth herein and should
also refer to the risk factors disclosure outlined in our annual
report on Form 10-K for the most recent fiscal year, our quarterly
reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
-----------------------------
John J. Lennon, President &
CEO
Investor Information:
Toll-Free: 1-877-358-5545 (FLU-KILL)
Web: www.uvflutech.com
Retail or Internet Inquires:
Please call our Corporate Office at: 508-362-5455
SOURCE UV Flu Technologies, Inc.